NEW YORK (

TheStreet

) --

Hi-Tech Pharmacal

(Nasdaq:

HITK

) hit a new 52-week high Monday as it is currently trading at $39.90, above its previous 52-week high of $39.60 with 40,022 shares traded as of 9:46 a.m. ET. Average volume has been 197,000 shares over the past 30 days.

Hi-Tech Pharmacal has a market cap of $500.7 million and is part of the

health care

sector and

drugs

industry. Shares are up 52.3% year to date as of the close of trading on Friday.

Hi Tech Pharmacal Co., Inc., a specialty pharmaceutical company, engages in developing, manufacturing, and marketing generic and prescription, over-the-counter (OTC), and nutritional products in liquid and semi-solid dosage forms in the United States. The company has a P/E ratio of 10.3, below the average drugs industry P/E ratio of 11 and below the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Hi-Tech Pharmacal as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full

Hi-Tech Pharmacal Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

null